Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Carbidopa and Levodopa Extended-release Tablets, USP(25 mg/100 mg and 50 mg/200 mg)Rx only
Medication labelWhy this: Advisory · dailymed-prescription
Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
- generic_name
- carbidopa and levodopa
- product_names
- CARBIDOPA and LEVODOPA
- ndc
- 60219-2033, 60219-2034, 60219-2033-3, 60219-2033-1, 60219-2033-5, 60219-2034-3, 60219-2034-1, 60219-2034-5
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en